Tuesday, June 26, 2007

Febit Files Infringement Complaint Against Codon

German biotech company Febit Biotech has filed a infringement complaint in the US District Court for the District of Delaware against Codon Devices alleging infringement of the US Patent # 6,586,211 (the ‘211 patent) pursuant to 35 USC § 271(a) and (g). In complaint, Febit alleged that Codon manufactures and uses a gene synthesis platform called the BioFAB platform which infringes literally or under doctrine of equivalents, one or more claims of the ‘211 patent. Febit is seeking compensatory damages under 35 USC § 284 and treble damages for willing infringement.

No comments:

Post a Comment